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Is the outcome of schizophrenia really better
in developing countries?
O prognóstico da esquizofrenia é realmente mais
favorável nos países em desenvolvimento?
Abst rac t
That schizophrenia has a better prognosis in non-industrialized societies has become an axiom in international psychiatry; the
evidence most often cited comes from three World Health Organization (WHO) cross-national studies. Although a host of socio-
cultural factors have been considered as contributing to variation in the course of schizophrenia in different settings, we have
little evidence from low-income countries that clearly demonstrates the beneficial influence of these variables. In this article,
we suggest that the finding of better outcomes in developing countries needs re-examination for five reasons: methodological
limitations of the World Health Organization studies; the lack of evidence on the specific socio-cultural factors which apparently
contribute to the better outcomes; increasing anecdotal evidence describing the abuse of basic human rights of people with
schizophrenia in developing countries; new evidence from cohorts in developing countries depicting a much gloomier picture
than originally believed; and, rapid social and economic changes are undermining family care systems for people with
schizophrenia in developing countries. We argue that the study of the long-term course of this mental disorder in developing
countries is a major research question and believe it is time to thoroughly and systematically explore cross-cultural variation in
the course and outcome of schizophrenia.
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Resumo
O fato de que a esquizofrenia possui um melhor prognóstico em sociedades não industrializadas tornou-se um axioma na
psiquiatria internacional; as evidências mais comumente citadas provêm de três estudos trans-nacionais da Organização Mundial
da Saúde (OMS). Ainda que um conjunto de fatores socioculturais tenha sido considerado como contribuinte para o curso da
esquizofrenia em diferentes ambientes, possuímos poucas evidências de países de baixa renda que demonstrem claramente a
influência benéfica dessas variáveis. Neste artigo, sugerimos que o achado de melhores desfechos em países em desenvolvimento
necessita ser reexaminado por cinco razões: falhas fundamentais nos estudos da Organização Mundial da Saúde; a falta de
evidências sobre os fatores socioculturais específicos que contribuem aparentemente para os melhores desfechos; as crescentes
evidências incidentais que descrevem o abuso dos direitos humanos das pessoas portadoras de esquizofrenia nos países em
desenvolvimento; novas evidências de coortes em países em desenvolvimento descrevendo um quadro muito mais sombrio do que
se pensava originalmente; e as rápidas transformações sociais e econômicas estão enfraquecendo os sistemas de atenção familiares
para pessoas com esquizofrenia nos países em desenvolvimento. Afirmamos que o estudo do curso de longo prazo desse transtorno
mental é fundamental e acreditamos que é tempo de explorar completa e sistematicamente a variação transcultural no curso e no
desfecho da esquizofrenia.
Descritores: Esquizofrenia; Comparação transcultural; Países em desenvolvimento; Violações dos direitos humanos; Prognóstico
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That schizophrenia has a bet ter  prognosis in non-
industrialized societies has become an axiom in international
psychiatry.  The most compelling evidence for this comes from
three cross-national studies conducted by the World Health
Organization: the International Pilot Study of Schizophrenia
(IPSS),1 the Determinants of Outcome of Severe Mental Disorder
(DOSMeD),2 and their successor, the International Study of
Schizophrenia (ISoS).3-4 The DOSMeD project, in particular,
represented the most ambit ious and methodological ly
sophisticated of these efforts in that the investigators attempted
to identify, over a period of two years, all persons suffering
from the first onset of schizophrenia in 13 catchment areas
located in 10 different countries. The most striking finding in
all of this research was ‘the existence of consistent and marked
differences in the prognosis of schizophrenia between the
centres in developed countries and the centres in developing
countries’.2 The DOSMeD investigators then went on to note
that the greatest contribution of their research was ‘not in
providing the answer[s]’ but in delineating questions about
how ‘societies and cultures shape the process of illness’.2
This is the DOSMeD challenge,5 but it has not been taken
up. Although a host of sociocultural factors have been cited
as contributing to variation in the course of schizophrenia in
different settings: family support and styles of interaction,
industrialization, and urbanization, in particular,6 we have
li t t le evidence from low-income countries that clearly
demonstrates the beneficent influence of these variables.
Indeed, the DOSMeD research did not provide any direct
sociocultural evidence to support its conclusions.5 Yet, its
findings and the evidence on which they were based, have
hardly been questioned.
This lack of critical assessment is curious, particularly when
later analyses of the DOSMeD and ISoS data have pointed to a
number of problems. For example, and true to earlier criti-
ques of the developing/developed world categories,5,7 one set
of secondary analyses of data from DOSMeD revealed that
although location, in general, was associated with patterns of
course, two sites in the developed world (Prague and
Nottingham) had outcomes that were similar to those in the
developing world, and outcomes in one developing world site
(Cali) were similar to those found in the developed world sites.8
A 15-year follow-up of subjects in the DOSMeD sites confirmed
the anomalous outcomes in Prague and Nottingham.3 The
most robust finding from these later analyses was that long-
term outcome was best predicted by ‘measures of early course,’
and while setting was associated with better chances of
recovery the ‘precise nature of these setting- or culture-specific
effects remains to be unraveled’.3
Thus, one is left with only questions about the ‘better
outcomes’ hypothesis. Following the cautions of Edgerton and
Cohen,5,7 the DOSMeD and ISoS investigators readily admitted
that the ‘black box’ of culture remained closed, and that the
socio-cultural factors which may influence outcome in
schizophrenia had not been revealed.3,8-9
We suggest that the apparent finding of a better outcome in
developing countries needs further re-examination for five major
reasons: 1) methodological limitations of the DOSMeD study;
2) the lack of evidence on the specific socio-cultural factors
which apparently contribute to the better outcomes; 3)
increasing anecdotal evidence describing the abuse of basic
human rights of people with schizophrenia in developing
countries; 4) new evidence from cohorts in developing
countries depicting a much gloomier picture than originally
believed; and, 5) rapid social and economic changes are
undermining family care systems for people with schizophrenia
in developing countries.
Even though DOSMeD has been cited as the ‘single most
important...finding’ in cross-cultural psychiatry,10 it suffered a
host of methodological problems: 1) while pointing to
differences in outcome as significant, the investigators
downplayed signif icant cross-national variat ion in the
incidence of broadly-defined schizophrenia or cultural
differences in subtypes of the disorder, and chose to place an
overwhelming emphasis on universal aspects of schizophrenia,
i.e., the lack of variation in the incidence of narrowly-defined
schizophrenia and the stability of the disorder at the syndrome
level;11 2) the multidimensional measures of outcome and
course lacked validity as variables such as percentage of the
follow-up period spent in the hospital or on psychotropic
medicat ion ref lected di f ferences in socioeconomic
environments rather than variations in course of illness; 3)
the failure to account for the much higher attrition rates in
the developing country sites; and, 4) the unfounded claim
that case ascertainment problems at five of the sites (Ibadan,
Moscow, Rochester, Agra, and Prague) would have been ‘of
little consequence’ regarding ‘the clinical...characteristics of
the patients’.2 Because the validity of schizophrenia research
depends, to a large extent, on whether all cases are identified
in a defined population over a fixed period of time,12 this last
point suggests a key limitation of the DOSMeD findings.7
At the same time, we have a great amount of evidence that
would make us expect that course and prognosis for
schizophrenia might be worse in low-income countries. We
know, for example, that severe stigma, lack of treatment, and
human rights abuses in large custodial asylums – all of which
are well-documented in many low-income countries – are
associated with poor course and outcome. Even though
landmark reports on the state of mental hospitals in South
and East Asia13-14 have described grotesque conditions of care
and violations of human rights, there has been little movement
to reform many of the hospitals. Nor are human rights abuses
restricted to mental hospitals. The Erwadi tragedy in South
India in 2001, in which more than 20 persons with mental
illness were burned to death when a fire swept one of the
treatment shelters near the healing mosque where they were
chained to their beds, is an example of the rights abuses which
take place under the guise of local medicine.15
In contrast to any notions of better outcomes, recent
investigations have reported unusually high mortality rates
in developing countries among persons with schizophrenia.
In the 15- to 25-year outcome studies of schizophrenia across
different countries, the proportion of subjects who died or
were lost to follow up ranged from 23% in Chennai to over
50% in the Chandigarh and Agra centres in India; it is
worrying that such a large number of persons could not be
traced in the two Indian centres.3 In a 20-year study in South
India, mortality for the cohort was high, (17%) and the
average age at death was only 34.2 years compared to 60.5
years, the average life span in India at that time.  Suicides –
all by persons younger than 35 years – accounted for nearly
half of all deaths (7 of 16).16 The paradox of a better
symptomatic outcome in developing countries was also
exemplified in  the results of the earlier IPSS.17  Even though
a better 2-year clinical outcome was reported for patients
from developing countries, at the 5-year follow-up, the
percentages of patients in Agra (India) and Ibadan (Nigeria)
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who had died were 9.0 and 7.1, respectively, compared with
4.9% for the entire study cohort. A recent epidemiological
study from Ethiopia confirmed high rates of mortality for
persons with schizophrenia: over 10% of subjects with
schizophrenia died during a follow up period of 1 to 4 years.18
Other research provides evidence that contradicts the ‘better
prognosis’ hypothesis. In Nigeria, a study looked at long-term
social outcomes among a group of persons with schizophrenia
who were receiving outpatient care.  Contrary to the expectation
that traditional family networks and supports would buffer these
patients against drifting down in socioeconomic status, these
patients continued to experience severe social disabilities in
multiple domains.19 Investigations in a rural district of Ethiopia
have also suggested that the course of schizophrenia may not
be particularly benign in the developing world. While functional
status was found to be relatively high in persons with
schizophrenia, this was primarily because they had full-time
employment working in the fields. At the same time, however,
most were actively psychotic and had experienced continuous
symptoms since the onset of illness.20 These initial findings
were later supported by a prospective study which found
persistently high levels of symptomatology and disability after
an average of 2.5 years.18
In Chennai (Madras), India, a 20 year prospective study of
90 persons with schizophrenia also provides evidence that
undermines the ‘better prognosis’ hypothesis. While a 10-year
follow-up revealed a ‘steep decline’ in both positive and negative
symptoms in the cohort, and that families were supportive
and caring, the ‘predominant pattern’ of course was repeated
psychotic episodes which were not always followed by
remission.21 This same pattern was found at the 20-year follow-
up.16 Furthermore, as noted above, this cohort was subjected
to high rates of mortality and suicide.
Ethnographic evidence f rom Chennai a lso provides
evidence that is at variance with the view that ‘traditional’
societies in developing countries are necessarily tolerant
and supportive of persons with severe mental disorders. A
study of women with schizophrenia whose marriages had
broken revealed a number of disturbing aspects about their
lives.22-23 They were the objects of ‘hostile and very negative
attitudes’ of other family members, held no jobs, and received
no support from their husbands.23 Furthermore, the women
were ‘ridiculed and ostracized’ for both being mentally ill
and divorced or separated.22
Evidence from surveys also suggests that persons with
psychosis do not live in societies that necessarily promote
recovery. In the late 1970’s, research revealed widespread
stigma toward persons with severe mental il lness, and
conjectured that such attitudes were responsible for the ‘not
uncommon’ sight of ‘mentally ill people roaming the streets
in tattered dresses or even naked’.24 More than 25 years
later, another survey of community attitudes found that a
broad cross section of the population held extremely negative
views of mental illness, believing that mentally ill persons
were dangerous.25
Thus, we are left with the DOSMeD Challenge5 to investigate
the social and cultural factors that may influence both the
short- and long-term course and prognosis of schizophrenia.
The question of the course and outcome of schizophrenia in
developing countries is profoundly important for two reasons.
First, it helps generate vital information regarding the health
needs of people, and families, affected by this disorder which,
in turn, may influence health policies. Secondly, such data
can help il luminate the role of sociocultural factors in
influencing the prognosis of this severe mental disorder and,
thereby, offer insights into possible intervention strategies of
potential universal applicability. Fur thermore, developing
countries are undergoing enormous sociocultural and health
status changes that may be of relevance to the occurrence
and outcome of psychotic disorders. Migration, urbanization,
changes in family structure and support ive networks,
increasing economic insecur i ty,  increasing global
competitiveness in employment opportunities, widening soci-
al inequalities, and growing privatization of health care may
profoundly influence the course and outcome of schizophrenia.
During the last 30 years, cross-cultural psychiatry has
embraced, almost without question, the notion that the
prognosis for schizophrenia is better in low-income countries
than in the wealthy countries of the West. Close examination
of the evidence, however, suggests a surprising, collective
willingness to accept what must be considered, at least by us,
unconfirmed beliefs about the perniciousness of the modern
and the benef icence of the t radi t ional.  Those bel iefs
notwithstanding, we believe it is time to investigate these
questions systematically. Echoing a sentiment that one of us
expressed some years ago,7 McGrath26 has suggested,
‘variations (in the incidence) should be seen as valuable
opportunities to generate and test novel candidate exposures’.
We think the same applies to the study of the long-term course
of outcome of this mental disorder and believe it is time to
thoroughly and systematically explore cross-cultural variation
in the course and outcome of schizophrenia.
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